|
|
|
|
| LEADER |
01855nam a2200301 u 4500 |
| 001 |
EB001888857 |
| 003 |
EBX01000000000000001052218 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200106 r ||| eng |
| 020 |
|
|
|a 9789241550437
|
| 245 |
0 |
0 |
|a WHO recommendations: Drug treatment for severe hypertension in pregnancy
|h Elektronische Ressource
|
| 246 |
3 |
1 |
|a Drug treatment for severe hypertension in pregnancy
|
| 260 |
|
|
|a Geneva
|b World Health Organization
|c 2018, [2018]
|
| 300 |
|
|
|a 1 PDF file (iv, 75 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Maternal Health Services
|
| 653 |
|
|
|a Hypertension, Pregnancy-Induced / drug therapy
|
| 653 |
|
|
|a Antihypertensive Agents / therapeutic use
|
| 653 |
|
|
|a Health Planning Guidelines
|
| 710 |
2 |
|
|a World Health Organization
|
| 740 |
0 |
2 |
|a WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a Continuation of WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK535778
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Improving care for women during pregnancy and around the time of childbirth to prevent and treat pre-eclampsia and eclampsia is a necessary step towards the achievement of the health targets of the Sustainable Development Goals (SDGs). Efforts to prevent and reduce morbidity and mortality due to these conditions can help address the profound inequities in maternal and perinatal health globally. To achieve this, healthcare providers, health managers, policy makers and other stakeholders need up-to-date and evidence-informed recommendations to guide clinical policies and practices
|